61: Guidance for Handling the Increasing Prevalence of Drugs Adulterated or Laced With Fentanyl
Listen now
Description
Joseph Parks, M.D., joins Dr. Dixon and Dr. Berezin to discuss guidelines for clinicians on how to deal with the increased prevalence of drugs adulterated with fentanyl and similar potent fentanyl analogs. MDI publications can be found here. Parks interview [00:53] The National Council for Mental Wellbeing [01:21] Guidelines [03:50] Contemplation [05:02] A back-to-basics approach [07:13] Fentanyl test strips and harm reduction [08:37] Spillover [10:06] Issues with fentanyl [12:05] Incremental behavioral changes [13:44] Things people should know about fentanyl [16:29] Training for professionals [18:03] How things are moving [19:55] See the Psychiatric Services Editor's Choice collection, "Responding to the Opioid Crisis." Transcript Subscribe to the podcast here. Check out Editor's Choice, a set of curated collections from the rich resource of articles published in the journal. Sign up to receive notification of new Editor's Choice collections. Browse other articles on our website. Be sure to let your colleagues know about the podcast, and please rate and review it wherever you listen to it. Listen to other podcasts produced by the American Psychiatric Association. Follow the journal on Twitter. E-mail us at [email protected]
More Episodes
Elizabeth Bromley, M.D., Ph.D. (University of California, Los Angeles) joins Dr. Dixon and Dr. Berezin to discuss the use of outpatient conservatorship in the effort to address mental health disability among unsheltered homeless persons in Los Angeles County, California. 00:00    Introduction...
Published 04/17/24
Gregory E. Simon, M.D., M.P.H. (Kaiser Permanente Washington Health Research Institute, Seattle) join Dr. Dixon and Dr. Berezin to discuss the use of machine learning models to analyze electronic health records to predict antidepressant treatment response. 00:00     Introduction 02:31    Focus...
Published 02/21/24